Latest Product Development News

xReality Group Limited delivered a record-breaking first quarter in FY26, driven by a landmark $5.7 million contract with the Texas Department of Public Safety and a rapidly growing US customer base.

Develop Global reports strong September quarter progress with Woodlawn mine ramping up on schedule and Sulphur Springs DFS doubling projected cashflow to A$1.5 billion. A major mining services contract extension further bolsters the company’s growth outlook.

ikeGPS Group reports a robust first half of FY26 with a 47% increase in subscription revenue exit run rate and launches PolePilot™, an AI-driven automation tool enhancing utility network analysis.

Audio Pixels Holdings has raised A$1.25 million through unsecured convertible notes from sophisticated investors, with the Chairman’s company poised to invest up to A$2 million pending shareholder approval. This funding boost aims to extend the company’s working capital runway and support its strategic goals.

Bega Cheese Limited reported robust FY2025 results marked by strategic site consolidations, innovation-led growth, and a strong financial position, setting the stage for an optimistic FY2026.

Sunrise Energy Metals has nearly doubled its scandium resource at the Syerston Project and attracted significant US government financing interest, underscoring the strategic value of its critical minerals assets amid tightening global supply.

The ACCC has approved Cuscal Limited’s acquisition of Indue Limited, concluding the deal won’t significantly reduce competition in payment facilitation services. The decision highlights ongoing industry consolidation balanced by multiple alternative providers and technological shifts.

ReNerve Limited reported a 38% increase in quarterly sales driven by the launch of its EmpliQ product range and ongoing development of advanced nerve repair technologies. The company’s cash position remains solid as it prepares for upcoming clinical trials.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

Nordic Resources has raised A$8.5 million in a strongly supported institutional placement to fund expanded exploration and development of its Finnish gold projects, with key assay results imminent.

Codan Limited reported a strong FY25 with significant revenue and profit growth, bolstered by a key U.S. acquisition and a robust outlook for FY26 driven by defense spending and gold market strength.